Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The role of communication in breast cancer screening: a qualitative study with Australian experts.

Parker LM, Rychetnik L, Carter SM.

BMC Cancer. 2015 Oct 19;15:741. doi: 10.1186/s12885-015-1749-0.

2.

Preconceptions influence women's perceptions of information on breast cancer screening: a qualitative study.

Henriksen MJ, Guassora AD, Brodersen J.

BMC Res Notes. 2015 Sep 3;8:404. doi: 10.1186/s13104-015-1327-1.

3.

A Review on Automatic Mammographic Density and Parenchymal Segmentation.

He W, Juette A, Denton ER, Oliver A, Martí R, Zwiggelaar R.

Int J Breast Cancer. 2015;2015:276217. doi: 10.1155/2015/276217. Epub 2015 Jun 11. Review.

4.

Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid.

Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Jacklyn G, Thornton H, Dhillon H, McCaffery K.

BMJ Open. 2014 Sep 25;4(9):e006016. doi: 10.1136/bmjopen-2014-006016.

5.

An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast disease.

Keyzer-Dekker CM, van Esch L, de Vries J, Ernst MF, Nieuwenhuijzen GA, Roukema JA, van der Steeg AF.

Breast Cancer Res Treat. 2012 Jul;134(1):253-8. doi: 10.1007/s10549-012-2025-5. Epub 2012 Mar 21.

6.

The breast screening programme and misinforming the public.

Gøtzsche PC, Jørgensen KJ.

J R Soc Med. 2011 Sep;104(9):361-9. doi: 10.1258/jrsm.2011.110078. Review.

7.

Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.

Taplin SH, Abraham L, Geller BM, Yankaskas BC, Buist DS, Smith-Bindman R, Lehman C, Weaver D, Carney PA, Barlow WE.

J Natl Cancer Inst. 2010 Jul 21;102(14):1040-51. doi: 10.1093/jnci/djq233. Epub 2010 Jul 2.

8.

What is the point: will screening mammography save my life?

Keen JD, Keen JE.

BMC Med Inform Decis Mak. 2009 Apr 2;9:18. doi: 10.1186/1472-6947-9-18.

9.

How does age affect baseline screening mammography performance measures? A decision model.

Keen JD, Keen JE.

BMC Med Inform Decis Mak. 2008 Sep 21;8:40. doi: 10.1186/1472-6947-8-40.

10.

The ethics of information: absolute risk reduction and patient understanding of screening.

Schwartz PH, Meslin EM.

J Gen Intern Med. 2008 Jun;23(6):867-70. doi: 10.1007/s11606-008-0616-y. Epub 2008 Apr 18.

11.

Social patterning of screening uptake and the impact of facilitating informed choices: psychological and ethical analyses.

Crockett R, Wilkinson TM, Marteau TM.

Health Care Anal. 2008 Mar;16(1):17-30. doi: 10.1007/s10728-007-0056-6. Epub 2007 Jun 28.

12.
13.
14.

Screening for breast cancer.

Dixon JM.

BMJ. 2006 Mar 4;332(7540):499-500. No abstract available.

16.

Model of outcomes of screening mammography: information to support informed choices.

Barratt A, Howard K, Irwig L, Salkeld G, Houssami N.

BMJ. 2005 Apr 23;330(7497):936. Epub 2005 Mar 8.

17.

Should women under 50 be screened for breast cancer?

Moss S.

Br J Cancer. 2004 Aug 2;91(3):413-7. Review.

18.
19.

Screening without evidence of efficacy: screening uncertainties concern evidence, efficacy, decisions.

Thornton H.

BMJ. 2004 Feb 28;328(7438):521; discussion 521-2. No abstract available.

20.

Women need better information on routine mammography: framing is important in presenting risk information.

Marshall TP.

BMJ. 2003 Oct 11;327(7419):868; author reply 869. No abstract available.

Supplemental Content

Support Center